Kiniksa Pharmaceuticals International, plc
For the period ended May 19, 2026. Filed Apr 16, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 19, 2026 · Filed Apr 16, 2026
KNSA$93.86+6.2%Stored close · as of Nov 6, 2026
Contents
Proxy Statement Summary
This summary highlights information contained elsewhere in this proxy statement and does not contain all of the important information that you should consider. As such, you should read the entire proxy statement carefully before voting.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.